Skip to content

Adding Letrozole to antagonist protocol in second ICSI attempt

Effect of adding letrozole to antagonist protocol for second ICSI attempt: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201308000582203
Enrollment
330
Registered
2013-07-04
Start date
2013-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female Women scheduled to second trial ICSI

Interventions

Letrozole
Control

Sponsors

Prof Dr Hassa Aly Hassan Elmaghraby
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Failed one attempt of ICSI in good responders (more than 3 Class A embryo transfer).

Exclusion criteria

Exclusion criteria: Poor response to ovarian stimulation as defined by ESHRE consensus (the Bologna criteria) (2011)

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy with cardiac pulsation

Secondary

MeasureTime frame
Blastocyst formation ;Spontaneous miscarriage

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026